Production (Stage)
Elanco Animal Health Incorporated
ELAN
$13.81
-$0.36-2.54%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 4.43B | 4.44B | 4.45B | 4.49B | 4.37B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 4.43B | 4.44B | 4.45B | 4.49B | 4.37B |
| Cost of Revenue | 2.00B | 2.00B | 2.02B | 2.01B | 1.95B |
| Gross Profit | 2.43B | 2.44B | 2.44B | 2.48B | 2.41B |
| SG&A Expenses | 1.31B | 1.31B | 1.30B | 1.29B | 1.29B |
| Depreciation & Amortization | 522.00M | 527.00M | 535.00M | 542.00M | 547.00M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.18B | 4.18B | 4.20B | 4.19B | 4.12B |
| Operating Income | 245.00M | 257.00M | 258.00M | 305.00M | 243.00M |
| Income Before Tax | 536.00M | 488.00M | 412.00M | -1.24B | -1.29B |
| Income Tax Expenses | 163.00M | 150.00M | 207.00M | 11.00M | 11.00M |
| Earnings from Continuing Operations | 373.00 | 338.00 | 205.00 | -1.26K | -1.30K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 373.00M | 338.00M | 205.00M | -1.26B | -1.30B |
| EBIT | 245.00M | 257.00M | 258.00M | 305.00M | 243.00M |
| EBITDA | 862.00M | 879.00M | 873.00M | 923.00M | 876.00M |
| EPS Basic | 0.75 | 0.68 | 0.41 | -2.55 | -2.64 |
| Normalized Basic EPS | 0.01 | 0.00 | -0.05 | -0.01 | -0.11 |
| EPS Diluted | 0.74 | 0.67 | 0.40 | -2.56 | -2.66 |
| Normalized Diluted EPS | 0.01 | 0.00 | -0.05 | -0.02 | -0.11 |
| Average Basic Shares Outstanding | 1.98B | 1.98B | 1.97B | 1.97B | 1.97B |
| Average Diluted Shares Outstanding | 1.99B | 1.98B | 1.98B | 1.98B | 1.97B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |